Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Supplementation as an Adjunct to Rifaximin in SIBO
NCT06223685Completed
- Sponsor
- Pomeranian Medical University in Szczecin
- Start
- Apr 2023
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Randomised, double-blind trial in small intestinal bacterial overgrowth (SIBO) (5 arms), sponsored by Pomeranian Medical University in Szczecin. Primary endpoints: Change in bloating on Visual Analog Score at 12 weeks and Change in bowel movements in a bowel-movement diary at 12 weeks. Started Apr 2023; status: completed.
02
Conditions
small intestinal bacterial overgrowth (SIBO)
Beyond the preview
Go deeper on NCT06223685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06223685.